Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Rossi

Showing results (251-260 of 341) with videos related to

Pageof 35
Sort By:
Cancer Science|July 15, 2010
Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinomaAlessandro Sgambato, Andrea Camerini, Giannicola Genovese, et al.
American Journal of Clinical Pathology|March 18, 2009
EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitorsGiuliana Sartori, Alberto Cavazza, Alessandro Sgambato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2013
Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligandsWilliam Vermi, Emanuele Giurisato, Silvia Lonardi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2013
Prognostic role of clusterin in resected adenocarcinomas of the lungFrancesca Panico, Christian Casali, Giulio Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2020
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experienceFilippo G Dall'Olio, Nicole Conci, Giulio Rossi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2011
Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimensGiuseppe Pelosi, Giulio Rossi, Fabrizio Bianchi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patientsPaola Bordi, Marcello Tiseo, Fausto Barbieri, et al.
The Journal of Pathology. Clinical Research|April 29, 2017
Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinomaAngelica Sonzogni, Fabrizio Bianchi, Alessandra Fabbri, et al.
Transplantation|October 27, 2011
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery?Leonardo Potenza, Patrizia Barozzi, Giulio Rossi, et al.
Frontiers in Cell and Developmental Biology|September 19, 2025
<i>SPARC</i> aberrant methylation in idiopathic pulmonary fibrosis: an explorative studyFederico Pio Fabrizio, Angelo Sparaneo, Flavia Centra, et al.
Pageof 35

Showing results (251-260 of 341) with videos related to

Sort By:
Pageof 35
Cancer Science|July 15, 2010
Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinomaAlessandro Sgambato, Andrea Camerini, Giannicola Genovese, et al.
American Journal of Clinical Pathology|March 18, 2009
EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitorsGiuliana Sartori, Alberto Cavazza, Alessandro Sgambato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2013
Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligandsWilliam Vermi, Emanuele Giurisato, Silvia Lonardi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2013
Prognostic role of clusterin in resected adenocarcinomas of the lungFrancesca Panico, Christian Casali, Giulio Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2020
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experienceFilippo G Dall'Olio, Nicole Conci, Giulio Rossi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2011
Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimensGiuseppe Pelosi, Giulio Rossi, Fabrizio Bianchi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patientsPaola Bordi, Marcello Tiseo, Fausto Barbieri, et al.
The Journal of Pathology. Clinical Research|April 29, 2017
Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinomaAngelica Sonzogni, Fabrizio Bianchi, Alessandra Fabbri, et al.
Transplantation|October 27, 2011
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery?Leonardo Potenza, Patrizia Barozzi, Giulio Rossi, et al.
Frontiers in Cell and Developmental Biology|September 19, 2025
<i>SPARC</i> aberrant methylation in idiopathic pulmonary fibrosis: an explorative studyFederico Pio Fabrizio, Angelo Sparaneo, Flavia Centra, et al.
Pageof 35